ClosedCorporate Number: 6180001133049Updated: 2026/10/06
株式会社オルリンクス製薬 (Corporate ID: 6180001133049) is a corporation headquartered in 愛知県名古屋市中区丸の内３丁目１８番２２号. Fully registered under Japan's National Tax Agency Qualified Invoice System (Invoice No: T6180001133049). Official contact (052-756-2660), corporate governance, and multi-year financial statements are openly accessible on Kigyou-list.
Official change history records regarding corporate name, registered address, and legal entity designations synced with Japan National Tax Agency (国税庁).
事由：令和７年１月１日名古屋市中区丸の内三丁目１８番２２号オルクス株式会社（5180001125617）に合併し解散
Reason: 令和７年１月１日名古屋市中区丸の内三丁目１８番２２号オルクス株式会社（5180001125617）に合併し解散
13-digit Corporate Number "6180001133049" was officially assigned by the National Tax Agency Commissioner with corporate name "株式会社オルリンクス製薬".
Cross-check reviews, press releases, and compliance background across top Japanese portals.
The official representative phone number for 株式会社オルリンクス製薬 is 052-756-2660. Head office is located at 愛知県名古屋市中区丸の内３丁目１８番２２号. Verified contact channels and executive directories are accessible on Kigyou-list.
株式会社オルリンクス製薬's official 13-digit National Tax Agency Corporate Number is 6180001133049. It is officially registered as a Qualified Invoice Issuer under Japan's consumption tax invoice system with registration ID T6180001133049.
株式会社オルリンクス製薬 is officially registered and headquartered at Postal Code 4600002, 愛知県名古屋市中区丸の内３丁目１８番２２号. Complete regional jurisdiction and legal relocation history are verified via Japan's National Tax Agency.
Outreach to 株式会社オルリンクス製薬 or acquire targeted lookalike company datasets.
株式会社オルリンクス製薬に関連する公的異動登記および愛知県の各カテゴリ別データベースへの直通インデックスです。 最新の法人登記データや採用活動の動向を各ハブにて毎日自動更新しています。
※ Corporate information on this profile is aggregated, verified, and structured based on official open data provided by the National Tax Agency (国税庁) and METI gBizINFO.
On Kigyou-list, users can review verified financial metrics, legal registry history, corporate signals (hiring, subsidies, trademarks), and export standardized CSV datasets for B2B intelligence.